14th - 15th September 2020

4th Annual MarketsandMarkets High Potent Medicines Virtual Conference ( Time Zone - CENTRAL EUROPEAN TIME (CET)

20+
Speaker
10+
Networking Hours
4
Sessions
150+
Attendees

The cytotoxic nature of HPAPIs presents significant handling challenges and thus requires heavy investments for implementing specialized containment facilities that facilitate the safety of employees from exposure. Owing to their target release characteristics, HPAPIs find major applications in target therapies for cancer. 

One of the major challenges faced by the players in this market, especially CMOs that offer HPAPI manufacturing services, is the continual evolution of industry standards, technologies, and regulations. 

MarketsandMarkets is proud to announce the 4th Annual High Potent Medicines Conference to be held on 14th - 15th September 2020 . This conference would address the challenges in the continual evolution of industry standards, technologies, and regulations. Leading experts from the industry will discuss the strategies for both in-house manufacturing and outsourcing by presenting expert keynote presentations, live case studies and breakthrough panel discussions.

users

Learn from 20+ industry-leading speakers who will be sharing their presentations on Challenges during the development of chemical processes of HPAPIs, Handling of highly potent products in a multi-product facility & Manufacturing Strategies for Highly Potent API’s

 

users

The 2-day event will share the latest industry trends, advancements and future growth in the highly potent medicines market where leading industry experts will discuss the strategies for both pharma and CMO’s

users

Expert keynote presentations, live case studies, and breakthrough panel sessions on Solutions to the challenges with regards to cleaning and validation in API Manufacturing and procedures to avoid cross-contamination.

Why Attend?

Utilizing the best practices to ensure the safe and efficient production of highly potent medicines

Training sessions on complex high potent compounds handling and containment issues

Understanding the updated regulatory guidelines in the HPAPI process

Implementing response plans to react to an unplanned event

Knowing the outsourcing strategies to effectively build a reliable supply chain

WHAT TO EXPECT
Key Highlights
  • Process Development and Scale Up of HPAPI’s
  • Risk Identification during Cleaning HPAPI’s
  • Cross-Contamination Prevention Case Studies
  • Containment and Handling Strategies
  • Regulatory Landscape
  • Hazard Assessment Classifications
Who Should Attend?
  • Chief executives
  • VP’s
  • Directors
  • Heads
  • Leaders
  • Senior Managers
  • Principal Scientists
  • Principal Toxicologists
  • Toxicologists
  • Fellows
  • Investigators
Departments
  • Research & Development
  • Manufacturing/Operations
  • Maintenance
  • Engineering
  • Risk Assessments
  • Laboratory Services/Analytical
  • New Technologies
  • Process Development/Technical transfer
  • Environmental, Health & Safety
  • Occupational Toxicology
  • Industrial Hygiene
  • New Products
  • Product Quality
  • Regulatory
  • Validation
  • Formulation Development
CONFERENCE AGENDA
CONFERENCE SPEAKERS
Speakers
Richard Denk

Richard Denk

Head Containment
SKAN AG, Switzerland

Richard Denk

Head Containment
SKAN AG, Switzerland
Ildiko Ziegler

Ildiko Ziegler

Quality Assurance Manager
Vanessa Research

Ildiko Ziegler

Quality Assurance Manager
Vanessa Research
Stefano Butti

Stefano Butti

Technical Sales Director
Food Pharma Systems, Italy

Stefano Butti

Technical Sales Director
Food Pharma Systems, Italy
Ester Lovsin Barle

Ester Lovsin Barle

Head, Product Stewardship and Health
Takeda, Switzerland

Ester Lovsin Barle

Head, Product Stewardship and Health
Takeda, Switzerland
Andreas Schreiner

Andreas Schreiner

Head of Validation
Novartis, Switzerland

Andreas Schreiner

Head of Validation
Novartis, Switzerland
Thomas Adam

Thomas Adam

Head of Global Quality Assurance Chemical APIs,
Bayer, Germany

Thomas Adam

Head of Global Quality Assurance Chemical APIs,
Bayer, Germany
Yossi Shapira

Yossi Shapira

Associate Director
MS&T S.M.E Teva Pharmaceuticals

Yossi Shapira

Associate Director
MS&T S.M.E Teva Pharmaceuticals
Martin Kohan

Martin Kohan

Senior Occupational Toxicologist
AstraZeneca, UK

Martin Kohan

Senior Occupational Toxicologist
AstraZeneca, UK
SPONSORS
Silver
example-image

FPS

Speaking Partner
example-image

PCI Pharma Services

example-image

Angelini

Leading Partner
example-image

Dec Group

PARTNERS
Media Partners
example-image

Medical events guide

PAST EVENT GALLERY